Valneva SE (France) Today
| VLA Stock | EUR 2.04 0.08 3.77% |
Performance0 of 100
| Odds Of DistressLess than 25
|
Valneva SE is trading at 2.04 as of the 22nd of November 2024, a 3.77 percent decrease since the beginning of the trading day. The stock's open price was 2.12. Valneva SE has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Valneva SE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. VALNEVA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. The company has 138.22 M outstanding shares. More on Valneva SE
Moving together with Valneva Stock
Moving against Valneva Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Valneva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Valneva SE's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Valneva SE or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Valneva SE (VLA) is traded on Euronext Paris in France and employs 762 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 762.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Valneva SE's market, we take the total number of its shares issued and multiply it by Valneva SE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Valneva SE operates under Healthcare sector and is part of Biotechnology industry. The entity has 138.22 M outstanding shares.
Valneva SE has accumulated about 329.77 M in cash with 76.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Valneva SE Probability Of Bankruptcy
Ownership AllocationValneva SE shows a total of 138.22 Million outstanding shares. Valneva SE has 17.56 % of its outstanding shares held by insiders and 21.63 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Valneva Ownership Details
Valneva SE Risk Profiles
Although Valneva SE's alpha and beta are two of the key measurements used to evaluate Valneva SE's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.09 | |||
| Standard Deviation | 2.83 | |||
| Variance | 8.0 | |||
| Risk Adjusted Performance | (0.20) |
Valneva Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Valneva SE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Valneva SE Corporate Management
Elected by the shareholders, the Valneva SE's board of directors comprises two types of representatives: Valneva SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Valneva. The board's role is to monitor Valneva SE's management team and ensure that shareholders' interests are well served. Valneva SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Valneva SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dipal Patel | Chief Board | Profile | |
| Frederic Jacotot | Gen IP | Profile | |
| Laetitia BachelotFontaine | VP Relations | Profile | |
| JuanCarlos MD | Chief Board | Profile | |
| Thomas Lingelbach | Pres Board | Profile | |
| Gerald Strohmaier | VP Resource | Profile | |
| Franck MBA | Chief Gen | Profile |
Other Information on Investing in Valneva Stock
Valneva SE financial ratios help investors to determine whether Valneva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.